Jason Mitchell Selected Research

Radiotherapy

4/2016

High-Dose, Single-Fraction Irradiation Rapidly Reduces Tumor Vasculature and Perfusion in a Xenograft Model of Neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason Mitchell Research Topics

Disease

3	Neoplasms (Cancer) 01/2018 - 12/2015
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2017 - 05/2017
1	COVID-19 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Chronic Disease (Chronic Diseases) 12/2017
1	Pyonephrosis 12/2017
1	Carcinogenesis 09/2017
1	Neuroblastoma 04/2016
1	Thrombosis (Thrombus) 10/2014
1	Ischemic Stroke 10/2014
1	Stroke (Strokes) 10/2014
1	Intracranial Thrombosis (Cerebral Thrombosis) 10/2014
1	Cerebral Infarction 10/2014
1	Supraventricular Tachycardia 11/2008

Drug/Important Bio-Agent (IBA)

1	Immune Checkpoint InhibitorsIBA 01/2018
1	SteroidsIBA 12/2017
1	Amino Acids FDA Link 09/2017
1	LectinsIBA 04/2016
1	Angiogenesis InhibitorsIBA 04/2016
1	Adenosine (Adenocard)FDA LinkGeneric 11/2008

Therapy/Procedure

3	Therapeutics 12/2017 - 12/2015
1	Mechanical Ventilators (Ventilator) 01/2021
1	Radiotherapy 04/2016
1	Endovascular Procedures 10/2014
1	Stents 10/2014
1	Thrombectomy 10/2014